A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This crucial tumor protector protein is frequently inactivated in various kinds of cancer, leading uncontrolled https://livebookmarking.com/story21950018/mini-antibodies-revive-tumor-suppressor-p53-a-promising-pathway-for-tumor-treatment